Mr. Richard S. Serbin serves as the President of Corporate Development and In-House Legal Counsel at Life Science Institute, LLC. Mr. Serbin is a global strategy advisor and entrepreneur with credentials both in pharmacy and law, complemented by more than 40 years of service as an FDA regulatory attorney and patent attorney in the healthcare industry. Mr. Serbin is an expert in licensing medical extracts, compounds, and technologies. He is a pharmacist and patent attorney with more than 25 years of experience in the pharmaceutical industry and the investment community. He served as Chief Executive Officer of Optigenex Inc. from July 2002 to September 15, 2005. From January 1999 until July 2002 Mr. Serbin served as a consultant to various pharmaceutical companies. He served as the President of Bradley Pharmaceuticals. He served as Vice President of Corporate Development at Ortho Pharmaceuticals, a Johnson & Johnson subsidiary, and practiced Patent and FDA law at Revlon Johnson & Johnson and Schering-Plough. He served as Patent Attorney for Schering Plough Corporation and Chief FDA Counsel for Revlon Corporation and Johnson and Johnson Corporation. Subsequently, he worked at Revlon Corporation, as its Chief Food, Drug and Cosmetic Counsel. He founded Radius Scientific Corporation. He plays an active role in developing business strategy and joint venture contacts and in guiding Mazal Plant Pharmaceuticals Inc. in regulatory compliance and investor relations. For the last 10 years, Mr. Serbin has been a Senior Advisor to the Swedish American Life Science Summit (SALSS), held annually in Stockholm, Sweden. He was J&J's Vice President of Corporate Development, and later led a successful public offering venture based on technology developed at Stanford Medical School. Mr. Serbin spent a large portion of his career focusing on international markets and clients. He worked on multiple international acquisitions and strategic relationships, and sat on the Board of Directors of several of its international subsidiaries, including those in India, Hong Kong, Japan, Taiwan, Germany, and England. He has been Head of Business Advisory Board at Mazal Plant Pharmaceuticals Inc. since October 11, 2006 and also serves as its Member of Business Advisory Board. He has been a Director at Rapid Nutrition Plc since November 18, 2014. He has been a Member of Advisory Board at Prime Access, Inc. since September 2015. He served as a Member of Scientific Advisory Board of Amazon Biotech, Inc. While at J&J, Mr. Serbin served on the Board of Directors of 16 US and international subsidiary companies, including Ethicon, Ortho, J&J Consumer Products, Pittman-Moore, Mc Neil, and J&J Development Corporation. He served as Director at Viropro Inc. until June 2014. He served as Director of Optigenex Inc. from July 30, 2004 to September 15, 2005. Mr. Serbin has a BS and a B. Pharmacy from Rutgers University and Rutgers University College of Pharmacy, a J.D. degree from Seton Hall Law School and a Masters Degree in Trade Regulations and Law from NYU Law School.

Dr. Strathe has been a practicing veterinarian for over 20 years. He is co-owner of one of the largest animal hospitals in Oklahoma. Dr. Strathe's interests include internal medicine, surgery, dentistry, and overall preventative health of his patients. Dr. Strathe has been involved with Cure Pharmaceutical the past 2 years. He has tested numerous products and compliance with his patients using the strip technology and delivery system. Dr. Strathe Graduated KSU vet school in 1993, Bachelors in Arts & Science KSU 1998.